Revisiting chronic rejection following living donor liver transplantation in the tacrolimus era: A single center experience.

Narendra Singh ChoudharyNeeraj SarafSanjiv SaigalDheeraj GautamAmit RastogiSanjay GojaPrashant BhanguiThiagrajan SrinivasanSanjay Kumar YadavArvinder Soin

Published in: Clinical transplantation (2019)

The incidence of chronic rejection is low in LDLT. Treatment with mTOR inhibitors can reverse graft dysfunction in approximately half of the patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
risk factors
oxidative stress